D-0914-2018 Class II Terminated

Recalled by Mckesson Packaging Services — Concord, NC

FDA drug recall D-0914-2018 was initiated by Mckesson Packaging Services on Feb 26, 2018 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Sep 15, 2020). Affected quantity: 17,192 cartons (1,719,200 tablets).

Recall details

Product Type
Drugs
Report Date
Mar 14, 2018
Initiation Date
Feb 26, 2018
Termination Date
Sep 15, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,192 cartons (1,719,200 tablets)

Product description

RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10

Reason for recall

Failed Stability Specifications

Distribution pattern

Nationwide

Code information

Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0914-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0914-2018. Report a data issue: hello@regdatalab.com.